U-Neuron Biomedical Inc
TPEX:6973
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
U-Neuron Biomedical Inc
TPEX:6973
|
TW |
|
Concord Medical Services Holdings Ltd
NYSE:CCM
|
CN |
|
Spey Resources Corp
OTC:SPEYF
|
CA |
|
L
|
Lubawa SA
WSE:LBW
|
PL |
|
T
|
Tunas Baru Lampung Tbk PT
F:T2L
|
ID |
|
Q
|
Qingling Motors Co Ltd
XMUN:QIN
|
CN |
Bankruptcy Probability
U-Neuron Biomedical Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Dec 31, 2025 | 615.5m |
| Jun 30, 2025 | 640m |
| Dec 31, 2024 | 748.8m |
| Jun 30, 2024 | 400.1m |
| Dec 31, 2025 | 6.2m |
| Jun 30, 2025 | 10.3m |
| Dec 31, 2024 | 12.6m |
| Jun 30, 2024 | 14.4m |
| Dec 31, 2025 | 12.4m |
| Jun 30, 2025 | 13.1m |
| Dec 31, 2024 | 0 |
| Jun 30, 2024 | 2.4m |
Solvency Ratios
Solvency Ratios Comparison
U-Neuron Biomedical Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
U
|
U-Neuron Biomedical Inc
TPEX:6973
|
1.7B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
464.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
238.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
59.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
U-Neuron Biomedical Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, U-Neuron Biomedical Inc has total debt of 12.4m TWD. This includes both short-term (0 TWD) and long-term (12.4m TWD) debt.
You can find a full breakdown on its Balance Sheet.
